Edition:
India

Mycronic AB (publ) (MYCR.ST)

MYCR.ST on Stockholm Stock Exchange

126.70SEK
19 Sep 2019
Change (% chg)

-1.40kr (-1.09%)
Prev Close
128.10kr
Open
127.60kr
Day's High
127.60kr
Day's Low
126.40kr
Volume
39,139
Avg. Vol
263,272
52-wk High
151.90kr
52-wk Low
91.70kr

Latest Key Developments (Source: Significant Developments)

Mycronic Receives Order For An Advanced Mask Writer
Monday, 15 Jul 2019 

July 15 (Reuters) - Mycronic AB (publ) ::MYCRONIC RECEIVES ORDER FOR AN ADVANCED MASK WRITER.ORDER CONSISTS OF A PREXISION-10 MASK WRITER, LIMITED TO PRODUCTION OF UP TO GENERATION 8 PHOTOMASK SIZE.ORDER FOR LIMITED PREXISION-10 SYSTEM IS VALUED BETWEEN USD 30-35 MILLION AND DELIVERY IS SCHEDULED FOR Q4 OF 2020..SYSTEM CAN LATER BE UPGRADED TO A FULL SCALE PREXISION-10 PRODUCTION SYSTEM.  Full Article

Mycronic Says AGM Decided Board For Period Running Until End Of Next AGM Shall Be Composed Of Six Members With No Deputy Members
Thursday, 9 May 2019 

May 9 (Reuters) - Mycronic AB (publ) ::AGM DECIDED THAT BOARD OF DIRECTORS FOR PERIOD RUNNING UNTIL END OF NEXT AGM SHALL BE COMPOSED OF SIX MEMBERS WITH NO DEPUTY MEMBERS.AGM RE-ELECTED BOARD MEMBERS ANNA BELFRAGE, KATARINA BONDE, ULLA-BRITT FRÄJDIN-HELLQVIST, ROBERT LARSSON AND PATRIK TIGERSCHIÖLD.AGM FURTHER ELECTED STAFFAN DAHLSTRÖM AS NEW BOARD MEMBER; PER HOLMBERG HAD DECLINED RE-ELECTION.PATRIK TIGERSCHIÖLD WAS RE-ELECTED CHAIRMAN OF BOARD.  Full Article

Mycronic Q1 EBIT Up At SEK 406 Mln
Thursday, 25 Apr 2019 

April 25 (Reuters) - Mycronic AB (publ) ::INTERIM REPORT JANUARY-MARCH 2019.Q1 ORDER INTAKE SEK 721 MILLION VERSUS SEK 656 MILLION YEAR AGO.Q1 NET SALES INCREASED 47 PERCENT TO SEK 1,105 (750) MILLION.Q1 EBIT WAS SEK 406 (196) MILLION.ASSESSMENT REMAINS CONSOLIDATED NET SALES FOR 2019 WILL BE AT LEVEL OF SEK 4 BILLION, EXCLUDING ANY ACQUISITIONS MADE IN 2019.WE HAD A GOOD START TO 2019.  Full Article

Mycronic Acquires U.S.-Based MRSI Systems
Friday, 1 Jun 2018 

June 1 (Reuters) - Mycronic AB (publ) ::MYCRONIC ACQUIRES MRSI SYSTEMS, LLC IN THE USA.PURCHASE PRICE AMOUNTS TO USD 40.7 MILLION (APPROXIMATELY SEK 358 MILLION) ON A CASH AND DEBT FREE BASIS.DEAL FINANCED WITH A COMBINATION OF MYCRONIC'S OWN FUNDS AND BANK FINANCING.UNDER CERTAIN PERFORMANCE PARAMETERS, AN EARN-OUT OF A MAXIMUM AMOUNT OF USD 20.2 MILLION WILL BE PAID IN 2020.ACQUISITION IS EFFECTIVE 1 JUNE 2018 AND EXPECTED TO CONTRIBUTE POSITIVELY TO UNDERLYING EBIT 2018.  Full Article

Mycronic says CEO Lena Olving to step down in 2019
Thursday, 22 Feb 2018 

Feb 22 (Reuters) - Mycronic AB (Publ) ::LENA OLVING LEAVES MYCRONIC DURING 2019.SAYS ‍AGREEMENT TERMS, WHICH HAVE BEEN DESCRIBED IN MYCRONIC'S ANNUAL REPORTS, INCLUDE AN AGREEMENT OF RETIREMENT AT AGE OF 62 WHICH COMES INTO EFFECT IN DECEMBER 2018​.SAYS ‍PROCESS TO FIND A SUCCESSOR HAS BEGUN​.SAYS ‍BOARD HAS EXTENDED EMPLOYMENT AGREEMENT WITH LENA OLVING, WHICH MEANS THAT LENA WILL REMAIN IN OFFICE AT LATEST UNTIL MAY 15, 2019​.  Full Article

Mycronic ‍Q4 EBIT At SEK 312 Mln
Wednesday, 7 Feb 2018 

Feb 7 (Reuters) - MYCRONIC AB (PUBL) ::Q4 ‍ORDER INTAKE WAS SEK 572 (518) MILLION​.‍Q4 NET SALES AMOUNTED TO SEK 931 (1,016) MILLION​.‍Q4 EBIT AMOUNTED TO SEK 312 (405) MILLION​.‍PROPOSES TO AGM A DIVIDEND OF SEK 2.50 (2.00) PER SHARE, IN ACCORDANCE WITH DIVIDEND POLICY.​.‍EARNINGS FOR AS WERE CHARGED WITH ACQUISITION-RELATED COSTS OF SEK 107 MILLION.​.‍"WE ARE SYSTEMATICALLY EVALUATING POSSIBLE ACQUISITIONS."​.  Full Article

Mycronic Q3 EBIT drops as Assembly Solutions unit weighs
Thursday, 19 Oct 2017 

Oct 19 (Reuters) - Mycronic AB (Publ) :Q3 ‍net sales were SEK 484 (497) million.Q3 ‍order intake was SEK 1,874 (367) million​​.Q3 ‍EBIT was SEK 63 (148) million​.Q3 ‍underlying ebit was sek 72 (149) million​.Says ‍board's assessment remains, that net sales in 2017 will be at level SEK 2,800 million.​.Says ‍we are not pleased with Q3 net sales and ebit regarding business area AS (Assembly Solutions)​.Says ‍quarter was negatively affected in short term by, among other things, challenges within supply chain for ramp up of platform changes​.  Full Article